SCHEMBL10148077

SCHEMBL10148077

CCn1c2ccccc2c2cc(C(N)=O)c(N)cc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.58
▸ LMNA P02545 7/20 0.58
▸ MAPK1 P28482 4/20 0.58
▸ POLB P06746 3/20 0.58
▸ MAPT P10636 10/20 0.56
▸ MEN1 O00255 7/20 0.56
▸ KMT2A Q03164 7/20 0.56
▸ ALDH1A1 P00352 6/20 0.56
▸ HPGD P15428 5/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ HTT P42858 2/20 0.56
▸ TDP1 Q9NUW8 2/20 0.56
▸ HBB P68871 1/20 0.56
▸ NPSR1 Q6W5P4 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ ALOX15 P16050 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13105848 0.82 KDM4E (0.45) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL10148197 0.81 TSPO (0.41) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL30150496 0.80 KDM4E (0.68) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL7979578 0.80 KDM4E (0.68) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL14036991 0.78 MAPT (0.64) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL398445 0.77 KDM4E (0.74) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL13979310 0.77 KDM4E (0.70) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL28922531 0.76 NPSR1 (0.56) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL10148088 0.76 POLB (0.41) KDM4ELMNAMAPK1POLBMAPT
SCHEMBL7838579 0.75 KDM4E (0.51) KDM4ELMNAMAPK1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101604-B2 Alpha carbolines and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-24 — — US disclosed
US-8101604-B2 Alpha carbolines and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2012-01-24 — — US disclosed
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-09 — — US disclosed
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-12-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311715-A1 ALPHA CARBOLINES AND USES THEREOF CHRM1, CNR1, CXCR1 KDM4E 2021/4885LMNA 3133/4885MAPK1 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback